Clinical Outcomes Of Precizon Presbyopic Intraocular Lens

To evaluate the clinical and visual outcomes, quality of vision and the influence of photic phenomena in patients bilaterally implanted with Precizon Presbyopic Intraocular lens (IOL).

Private practice.

In this prospective consecutive case series, 40 eyes of 20 patients were included (mean age 60.6 ±7.77). The main outcome parameters were postoperative corrected / uncorrected VA at distance, intermediate and near (LogMAR). Manifest refraction spherical equivalent (MRSE) was measured as a secondary outcome parameter. Patient satisfaction and quality of vision was inquired by the means of questionnaires and contrast sensitivity testing. The follow-up was at least four months after surgery.

At 4 months after surgery, MRSE improved from -0.54 D ± 4.98 D to 0.07 D ± 0.62 D. Mean monocular uncorrected distance visual acuity (UDVA) improved to -0.04 ±0.05 LogMAR. Mean binocular distance corrected intermediate visual acuity (DCIVA), distance corrected near visual acuity (DCNVA), and uncorrected near visual acuity (UNVA) were respectively 0.03 ± 0.08, 0.23 ± 0.17, and 0.15 ± 0.12 LogMAR. Contrast sensitivity was within the normal range for all tested light conditions. Data from questionnaires showed only 7% of patients have experienced photic phenomena often, 29% occasionally, and 64% not at all. 95% of patients were spectacle independent.

Precizon Presbyopic IOL (OPHTEC BV) provides a high percentage of spectacle independence due to an excellent visual acuity and quality at far, intermediate and near distances. Patients reported low levels of photic phenomena.